TB-500 · 5 MG | Tímosina Beta-4 Sintética

TB-500: La Clave para una Recuperación Acelerada de Músculos y Articulaciones

Para el atleta de alto rendimiento, fisicoculturista y cualquier persona que busque optimizar su recuperación, la capacidad de sanar tejidos dañados es fundamental. TB-500 es un péptido sintético derivado de la Tímosina Beta-4, una proteína natural que desempeña un papel esencial en la migración celular, la regeneración de tejidos y la modulación de la inflamación . Actúa como un acelerador de la recuperación, diseñado para ayudarte a sanar más rápido, moverte mejor y mantenerte en el juego por más tiempo.

Movilidad y Reparación Avanzada

En esencia, TB-500 se enfoca en restaurar tu función completa de manera rápida. Potencia los mecanismos de reparación innatos del cuerpo, promoviendo la migración de células regenerativas hacia los tejidos dañados . El resultado es una mejora notable en el rango de movimiento, reducción de la rigidez y una recuperación visible en el rendimiento articular y muscular.

Beneficios para el Tejido Conectivo

Este péptido ha demostrado en estudios preclínicos un potencial significativo para la reparación de músculos, tendones y ligamentos—tejidos que, por su limitado suministro sanguíneo, sanan de manera especialmente lenta . Al regular la dinámica de la actina, una proteína estructural clave para el movimiento celular, TB-500 facilita la migración de fibroblastos y otras células reparadoras a las áreas lesionadas .

Recuperación Post-Entrenamiento y Reducción del Tiempo de Inactividad

Los atletas que utilizan TB-500 reportan una reducción significativa en el tiempo de recuperación después de entrenamientos intensos o lesiones. Al reducir la inflamación y promover la angiogénesis (formación de nuevos vasos sanguíneos), este péptido acelera el suministro de oxígeno y nutrientes a los tejidos dañados , permitiendo volver al entrenamiento de manera más constante y consistente.

Evidencia Científica y Estatus Regulatorio

La evidencia científica sobre TB-500 se basa principalmente en estudios preclínicos y reportes observacionales, con datos clínicos en humanos aún limitados . Es importante destacar que TB-500 está prohibido por la Agencia Mundial Antidopaje (WADA) bajo la categoría S0 y S2 , y no está aprobado por la FDA para uso humano . Este producto es exclusivamente para investigación científica.

Key Benefits of TB-500 Accelerated Tissue Repair: TB-500 promotes the migration of repair cells to damaged tissues, accelerating recovery of muscles, tendons, ligaments, and skin, as documented in preclinical models . Improved Mobility and Range of Motion: By reducing inflammation and repairing connective tissue, improvements in flexibility and joint mobility are observed . Angiogenesis Promotion: Stimulates the formation of new blood vessels through HIF-1α/VEGF and Notch signaling pathways, a crucial process for delivering oxygen and nutrients to damaged tissue and accelerating healing . Inflammation Reduction: Modulates the inflammatory response, suppressing NF-κB activation and reducing pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 . Reduced Scar Tissue Formation: Its anti-inflammatory and tissue-remodeling properties may support more organized healing with less fibrosis, reducing the number of myofibroblasts in wounds . Reduced Downtime: Accelerates post-injury and post-workout recovery, allowing greater training frequency and intensity .

Function and Mechanism of Action of TB-500 TB-500 is a synthetic peptide derived from Thymosin Beta-4 (Tβ4), a natural 43-amino acid protein that plays a fundamental role in cell migration, tissue regeneration, and angiogenesis . Mechanism of Action: Actin Regulation: TB-500 binds to G-actin (actin monomer) and regulates its polymerization, controlling the dynamics of the actin cytoskeleton, which is essential for cell migration and movement . Cell Migration: By modulating actin dynamics, TB-500 promotes the migration of fibroblasts, endothelial cells, and other repair cells to sites of tissue damage . Angiogenesis: Stimulates the formation of new blood vessels through HIF-1α/VEGF and Notch signaling pathways, improving oxygen and nutrient supply to repairing tissues . Inflammation Modulation: Suppresses NF-κB transcription factor activation, reducing the production of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 . Anti-Fibrotic Effect: Reduces scar formation by decreasing the number of myofibroblasts in wounds, facilitating more organized tissue repair

How to Use TB-500 Route of Administration: Injectable via subcutaneous (SC) or intramuscular (IM). For systemic effect, subcutaneous administration is recommended . Reconstitution: The product is presented as a lyophilized powder in a vial. It must be reconstituted with bacteriostatic water for injection before use. Research Protocol: Dosage and frequency must be determined by the researcher according to protocol goals. Common research protocols use doses of 2.5-5 mg per administration, with cycles of 4 to 8 weeks to observe reported changes . Storage: Store in a cool, dry place, protected from light. Once reconstituted, refrigerate. Important Notice: Product intended EXCLUSIVELY FOR SCIENTIFIC RESEARCH.

Ingredients of TB-500 Active Ingredient: TB-500 (Synthetic Thymosin Beta-4): A synthetic 17-amino acid peptide derived from the natural protein Thymosin Beta-4. It is responsible for actin regulation, cell migration, angiogenesis, and inflammation modulation . Excipients: Mannitol: A sugar alcohol that acts as a cryoprotectant and bulking agent, used to stabilize the peptide structure during the lyophilization process. Water for Injection (WfI): High-purity water used as a vehicle in the lyophilization process to create the sterile powder. Note for Consumers: This product is a high-purity synthetic peptide, manufactured without unnecessary additives, preservatives, or fillers.

Onset Time &amp;amp;amp; Expected Results of TB-500 For researchers seeking to understand timelines, current evidence (primarily preclinical) suggests the following progression for TB-500: Onset of Action (Days): Initial effects related to reduced inflammation and pain may be observed within the first days of administration . Measurable Benefits (2-4 Weeks): Significant tissue repair and mobility improvement begin to become observable in this period, especially in tendon and ligament injuries . Full Effect (4-8 Weeks): For chronic conditions or complete soft tissue recovery, the full therapeutic effect often requires 4 to 8 weeks of consistent use according to the research protocol . Influencing Factors: The speed and magnitude of results depend on the severity and type of injury, the individual&amp;amp;#039;s age, nutritional status, and adherence to the research protocol.

Clinical Research &amp;amp;amp; 3rd Party Test Results of TB-500 Current scientific evidence on TB-500, up to 2026, is based primarily on preclinical studies in animal models and cells, with limited observational studies in humans. A 2026 scoping review found that the literature on TB-500 in musculoskeletal tissue repair is broad but uneven, dominated by preclinical evidence centered on Thymosin Beta-4 rather than TB-500 specifically . Preclinical Evidence: Actin Regulation: TB-500 binds to G-actin and regulates polymerization, controlling cell migration . Angiogenesis: Stimulates new blood vessel formation through HIF-1α/VEGF pathways . Inflammation Modulation: Suppresses NF-κB activation, reducing pro-inflammatory cytokines . Connective Tissue Repair: Research in tendons and ligaments shows TB-500 accelerates repair and restores loading capacity . Anti-Fibrotic Effect: Reduces scar formation by decreasing the number of myofibroblasts . Human Evidence: Limited: Direct evidence for TB-500 in humans is minimal . A small Phase 2 clinical trial with topical TB-500 showed complete healing in approximately 25% of patients with venous ulcers within 3 months . Ongoing Clinical Trials: A Phase 1/2 clinical trial (NCT07487363) is currently underway to evaluate the safety and tolerability of TB-500 in adults with stable atherosclerotic cardiovascular disease . Regulatory Status: TB-500 is not FDA-approved for any human use and is classified as Category 2 (substance of safety concern). It is prohibited by WADA under categories S0 and S2 . Syntex Labs Standards: Lab Grade: Purity ≥99%. QR Tracking: Complete batch traceability. Secure Batch Label: &amp;amp;quot;Scratch to See&amp;amp;quot; security system. 3rd Party Results: Access to Certificates of Analysis (COA).

Product Details

TB-500 · 5 MG | Tímosina Beta-4 Sintética

TB-500 · 5 MG | Tímosina Beta-4 Sintética

Build Your Stack

Frequently Asked Questions